Transgenic Group Inc.

¥197.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:2342Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (10.23%)
Div yield —
ROE 0.57%
Biotechnology
Beta (5Y) 0.46
PE TTM 99.41
TSR TTM 1.03%
Mkt cap ¥3.281B
ROIC 5.10%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥218
10.73%
(53.13%)
Hold 11|12|11|3|9
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
4.47
4.96
5.15
5.40
3.22%
18.37%
21.65%
21.78%
Revenue¥M
261.2
273.2
266.1
275.9
6.07%
8.15%
3.74%
10.85%
Peers (US$20.83M)
Cap (US$)
PE
20.20M
—
20.68M
—
Capital
TTM
5Y
10Y
Leveragex
2.895
1.559
1.579
EBIT/Intx
0.955
1.803
1.806
Own earn%
(8.46)
177.97
132.33
Sh yield%
12.01
39.58
39.09
Owners
Insiders/Inst%
2.86
53.08
Short interest%
2.20
SBC / revenue%
4.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
18–27
$1 testx
0.0
Incr. ROIC%
2